Close Menu

360Dx

Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.

The German biotech firm said its lateral flow blood test does not detect subclinical HPV infection but picks up on HPV-induced cancers and pre-cancers.

The company is drawing on its previous experience developing and commercializing its HIV self-test to make progress on a test that could be used for three different indications.